MDXG
Price
$5.76
Change
+$0.04 (+0.70%)
Updated
Oct 4 closing price
23 days until earnings call
RXRX
Price
$6.11
Change
+$0.05 (+0.83%)
Updated
Oct 4 closing price
31 days until earnings call
Ad is loading...

MDXG vs RXRX

Header iconMDXG vs RXRX Comparison
Open Charts MDXG vs RXRXBanner chart's image
MiMedx Group
Price$5.76
Change+$0.04 (+0.70%)
Volume$410.05K
CapitalizationN/A
Recursion Pharmaceuticals
Price$6.11
Change+$0.05 (+0.83%)
Volume$3.85M
CapitalizationN/A
View a ticker or compare two or three
MDXG vs RXRX Comparison Chart
Loading...
MDXG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
MDXG vs. RXRX commentary
Oct 07, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MDXG is a StrongBuy and RXRX is a Sell.

COMPARISON
Comparison
Oct 07, 2024
Stock price -- (MDXG: $5.76 vs. RXRX: $6.11)
Brand notoriety: MDXG and RXRX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: MDXG: 59% vs. RXRX: 73%
Market capitalization -- MDXG: $867.64M vs. RXRX: $1.97B
MDXG [@Biotechnology] is valued at $867.64M. RXRX’s [@Biotechnology] market capitalization is $1.97B. The market cap for tickers in the [@Biotechnology] industry ranges from $531.34B to $0. The average market capitalization across the [@Biotechnology] industry is $2.87B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MDXG’s FA Score shows that 1 FA rating(s) are green whileRXRX’s FA Score has 0 green FA rating(s).

  • MDXG’s FA Score: 1 green, 4 red.
  • RXRX’s FA Score: 0 green, 5 red.
According to our system of comparison, both MDXG and RXRX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MDXG’s TA Score shows that 4 TA indicator(s) are bullish while RXRX’s TA Score has 3 bullish TA indicator(s).

  • MDXG’s TA Score: 4 bullish, 4 bearish.
  • RXRX’s TA Score: 3 bullish, 5 bearish.
According to our system of comparison, MDXG is a better buy in the short-term than RXRX.

Price Growth

MDXG (@Biotechnology) experienced а -1.20% price change this week, while RXRX (@Biotechnology) price change was -12.46% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.46%. For the same industry, the average monthly price growth was +1.89%, and the average quarterly price growth was -5.77%.

Reported Earning Dates

MDXG is expected to report earnings on Oct 29, 2024.

RXRX is expected to report earnings on Mar 04, 2025.

Industries' Descriptions

@Biotechnology (+1.46% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RXRX($1.97B) has a higher market cap than MDXG($868M). MDXG YTD gains are higher at: -34.322 vs. RXRX (-38.032). MDXG has higher annual earnings (EBITDA): 66.8M vs. RXRX (-348.35M). RXRX has more cash in the bank: 474M vs. MDXG (69M). MDXG has less debt than RXRX: MDXG (19.2M) vs RXRX (89.9M). MDXG has higher revenues than RXRX: MDXG (340M) vs RXRX (48.6M).
MDXGRXRXMDXG / RXRX
Capitalization868M1.97B44%
EBITDA66.8M-348.35M-19%
Gain YTD-34.322-38.03290%
P/E Ratio10.37N/A-
Revenue340M48.6M700%
Total Cash69M474M15%
Total Debt19.2M89.9M21%
FUNDAMENTALS RATINGS
MDXG: Fundamental Ratings
MDXG
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
64
Fair valued
PROFIT vs RISK RATING
1..100
92
SMR RATING
1..100
12
PRICE GROWTH RATING
1..100
82
P/E GROWTH RATING
1..100
92
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
MDXGRXRX
RSI
ODDS (%)
Bullish Trend 3 days ago
81%
N/A
Stochastic
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
83%
Momentum
ODDS (%)
Bearish Trend 3 days ago
81%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
72%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
78%
Bearish Trend 3 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 3 days ago
75%
Bullish Trend 3 days ago
82%
Advances
ODDS (%)
Bullish Trend 7 days ago
83%
Bullish Trend 11 days ago
82%
Declines
ODDS (%)
Bearish Trend 4 days ago
79%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
81%
Aroon
ODDS (%)
Bearish Trend 3 days ago
80%
Bearish Trend 3 days ago
90%
View a ticker or compare two or three
Ad is loading...
MDXG
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
RXRX
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
SMEAX15.400.22
+1.45%
Invesco Small Cap Equity A
CDOFX49.190.53
+1.09%
Crawford Small Cap Dividend
VMVAX86.560.63
+0.73%
Vanguard Mid-Cap Value Index Admiral
EXEYX16.090.09
+0.56%
Manning & Napier Equity Series S
TGVIX29.99-0.05
-0.17%
Thornburg International Equity I

MDXG and

Correlation & Price change

A.I.dvisor indicates that over the last year, MDXG has been loosely correlated with NTLA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if MDXG jumps, then NTLA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MDXG
1D Price
Change %
MDXG100%
+0.70%
NTLA - MDXG
52%
Loosely correlated
+1.93%
RCKT - MDXG
51%
Loosely correlated
+2.18%
BEAM - MDXG
51%
Loosely correlated
+2.05%
VCEL - MDXG
50%
Loosely correlated
+4.86%
TECH - MDXG
49%
Loosely correlated
+1.05%
More

RXRX and

Correlation & Price change

A.I.dvisor indicates that over the last year, RXRX has been loosely correlated with BEAM. These tickers have moved in lockstep 61% of the time. This A.I.-generated data suggests there is some statistical probability that if RXRX jumps, then BEAM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RXRX
1D Price
Change %
RXRX100%
+0.83%
BEAM - RXRX
61%
Loosely correlated
+2.05%
NTLA - RXRX
58%
Loosely correlated
+1.93%
CRSP - RXRX
57%
Loosely correlated
+1.05%
PRME - RXRX
55%
Loosely correlated
+2.93%
KYMR - RXRX
51%
Loosely correlated
-0.81%
More